Catalys Pacific, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 10, 2026, for the 2025 Q4 period, Catalys Pacific, LLC held in its portfolio 2 assets valued at $310,537,623 (i.e. $310.54M).

The most valuable assets in the portfolio included: Mineralys Therapeutics, Inc. ($286.83M), and Phathom Pharmaceuticals, Inc. ($23.71M),

The chart below shows the top 2 valuable assets, and the table below shows the top 2 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Catalys Pacific, LLC Portfolio

Mineralys Therapeutics, Inc.

Phathom Pharmaceuticals, Inc.

Catalys Pacific, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Mineralys Therapeutics, Inc.	7903838	286830281	COM
Phathom Pharmaceuticals, Inc.	1429014	23707342	COM